Quick links
Member links
Categories
Publications & Presentations
Discover the main highlights of our industry in our latest publications.
Access to Care
Discover a complete record of access to care issues by region and PPTA activities in support of access to therapies.
Safety & Quality
Learn more about the regulatory policies and the Association’s voluntary standards for safety & quality standards.
Plasma Collection & Manufacturing
Learn more about plasma collection and discover certified plasma centers near you.
The Source Magazine
Subscribe to the international magazine of the plasma protein therapeutics industry.
Plasma FAQS
Get answers about plasma therapies and the processes surrounding donation and collection procedures.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Oct 28, 2026
Maintaining Immunoglobulins on the Union List of Critical Medicines to Safeguard Patient Access
As the review of the Union List of Critical Medicines (ULCM) approaches its conclusion, the Plasma Protein Therapeutics Association (PPTA) strongly supports maintaining human normal immunoglobulins (IG) on the Union list1 as they are lifesaving, irreplaceable treatments of human origin facing ongoing supply challenges. Maintaining IG on the Union list supports the EU’s broader agenda to strengthen the resilience, security and sustainability of medicines supply as well as safeguard reliable access for patients across Europe.
All
PPTA Statements
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/6ae22ea3cac65bcf56c49109_FINAL%20PPTA%20statement%20on%20Union%20List%20of%20Critical%20Medicines_28.10.2026.pdf
Oct 28, 2026
Maintaining Immunoglobulins on the Union List of Critical Medicines to Safeguard Patient Access
As the review of the Union List of Critical Medicines (ULCM) approaches its conclusion, the Plasma Protein Therapeutics Association (PPTA) strongly supports maintaining human normal immunoglobulins (IG) on the Union list1 as they are lifesaving, irreplaceable treatments of human origin facing ongoing supply challenges. Maintaining IG on the Union list supports the EU’s broader agenda to strengthen the resilience, security and sustainability of medicines supply as well as safeguard reliable access for patients across Europe.
All
PPTA Statements
https://cdn.prod.website-files.com/6916f1777886bb3b9377a752/6ae22ea3cac65bcf56c49109_FINAL%20PPTA%20statement%20on%20Union%20List%20of%20Critical%20Medicines_28.10.2026.pdf
Oct 21, 2026
Plasma Protein Forum to Convene in Alexandria, VA
All
Press Releases
Oct 21, 2026
Plasma Protein Forum to Convene in Alexandria, VA
All
Press Releases
No results found